{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:36:16Z","timestamp":1787960176423,"version":"build-2784847793"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Cardiac resynchronization therapy (CRT) confers morbidity and mortality benefits to selected patients with heart failure. This systematic review examined effects of CRT in CKD patients (estimated GFR [eGFR] &lt;60 ml\/min per 1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, setting, participants, &amp; measurements<\/jats:title>\n                    <jats:p>\n                      MEDLINE and Scopus (from 1990 to December 2012) and conference proceedings abstracts were searched for relevant observational studies and randomized controlled trials (RCTs). Studies comparing the following outcomes were included: (\n                      <jats:italic toggle=\"yes\">1<\/jats:italic>\n                      ) CKD patients with and without CRT and (\n                      <jats:italic toggle=\"yes\">2<\/jats:italic>\n                      ) CKD patients with CRT to non-CKD patients with CRT. Mortality, eGFR, and left ventricular ejection fraction data were extracted and pooled when appropriate using a random-effects model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eighteen studies (14 observational studies and 4 RCTs) were included. There was a modest improvement in eGFR with CRT among CKD patients (mean difference 2.30 ml\/min per 1.73m\n                      <jats:sup>2<\/jats:sup>\n                      ; 95% confidence interval, 0.33 to 4.27). Similarly, there was a significant improvement in left ventricular ejection with CRT in CKD patients (mean difference 6.24%; 95% confidence interval, 3.46 to 9.07). Subgroup analysis of three RCTs reported lower rates of death or hospitalization for heart failure with CRT (versus other therapy) in the CKD population. Survival outcomes of CKD patients (compared with the non-CKD population) with CRT differed among observational studies and RCTs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CRT improves left ventricular and renal function in the CKD population with heart failure. Given the increasing use of cardiac devices, further studies examining the effects of CRT on mortality in CKD patients, particularly those with advanced kidney disease, are warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.00750113","type":"journal-article","created":{"date-parts":[[2013,5,10]],"date-time":"2013-05-10T01:14:57Z","timestamp":1368148497000},"page":"1293-1303","source":"Crossref","is-referenced-by-count":31,"title":["Cardiac Resynchronization Therapy in CKD"],"prefix":"10.2215","volume":"8","author":[{"given":"Neha","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Rickard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph V.","family":"Nally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.H. Wilson","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sankar D.","family":"Navaneethan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20230811","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States.","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"key":"R2-6-20230811","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"R3-6-20230811","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1681\/ASN.2012020145","article-title":"Associations between kidney function and subclinical cardiac abnormalities in CKD.","volume":"23","author":"Park","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R4-6-20230811","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2215\/CJN.00070109","article-title":"Chronic Renal Insufficiency Cohort (CRIC) Study: Baseline characteristics and associations with kidney function.","volume":"4","author":"Lash","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R5-6-20230811","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jama.2011.1201","article-title":"Progression of left ventricular diastolic dysfunction and risk of heart failure.","volume":"306","author":"Kane","year":"2011","journal-title":"JAMA"},{"key":"R6-6-20230811","doi-asserted-by":"crossref","first-page":"R292","DOI":"10.1152\/ajpregu.00194.2011","article-title":"Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: A kidney-heart connection.","volume":"302","author":"Martin","year":"2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R7-6-20230811","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1681\/ASN.2006101159","article-title":"Reduced kidney function as a risk factor for incident heart failure: The atherosclerosis risk in communities (ARIC) study.","volume":"18","author":"Kottgen","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R8-6-20230811","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1001\/jama.2012.14785","article-title":"Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction.","volume":"308","author":"Lund","year":"2012","journal-title":"JAMA"},{"key":"R9-6-20230811","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1001\/archinte.166.17.1884","article-title":"Cardiovascular disease risk factors in chronic kidney disease: Overall burden and rates of treatment and control.","volume":"166","author":"Parikh","year":"2006","journal-title":"Arch Intern Med"},{"key":"R10-6-20230811","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jacc.2004.06.072","article-title":"The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease.","volume":"44","author":"Ezekowitz","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R11-6-20230811","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.hrthm.2010.09.005","article-title":"Relation between renal function and response to cardiac resynchronization therapy in Multicenter Automatic Defibrillator Implantation Trial\u2014Cardiac Resynchronization Therapy (MADIT-CRT).","volume":"7","author":"Goldenberg","year":"2010","journal-title":"Heart Rhythm"},{"key":"R12-6-20230811","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/j.ajkd.2007.11.021","article-title":"Therapies for acute heart failure in patients with reduced kidney function: A community-based perspective.","volume":"51","author":"Goldberg","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R13-6-20230811","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.jacc.2007.07.067","article-title":"Incidence and predictors of hyperkalemia in patients with heart failure: An analysis of the CHARM Program.","volume":"50","author":"Desai","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R14-6-20230811","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.hrthm.2008.04.014","article-title":"ACC\/AHA\/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities.","volume":"5","author":"Epstein","year":"2008","journal-title":"Heart Rhythm"},{"key":"R15-6-20230811","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.hrthm.2012.08.021","article-title":"2012 ACCF\/AHA\/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the american college of cardiology Foundation\/American heart association task force on practice guidelines.","volume":"9","author":"Tracy","year":"2012","journal-title":"Heart Rhythm"},{"key":"R16-6-20230811","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2008.08.027","article-title":"Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.","volume":"52","author":"Linde","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R17-6-20230811","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.jacc.2005.05.094","article-title":"Improvements in left ventricular diastolic function after cardiac resynchronization therapy are coupled to response in systolic performance.","volume":"46","author":"Waggoner","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R18-6-20230811","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.","volume":"350","author":"Bristow","year":"2004","journal-title":"N Engl J Med"},{"key":"R19-6-20230811","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"Cardiac-resynchronization therapy for the prevention of heart-failure events.","volume":"361","author":"Moss","year":"2009","journal-title":"N Engl J Med"},{"key":"R20-6-20230811","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa013168","article-title":"Cardiac resynchronization in chronic heart failure.","volume":"346","author":"Abraham","year":"2002","journal-title":"N Engl J Med"},{"key":"R21-6-20230811","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2004030203","article-title":"Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999.","volume":"16","author":"Foley","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R22-6-20230811","doi-asserted-by":"crossref","first-page":"427","DOI":"10.7326\/0003-4819-144-6-200603210-00010","article-title":"Evaluation of the quality of prognosis studies in systematic reviews.","volume":"144","author":"Hayden","year":"2006","journal-title":"Ann Intern Med"},{"key":"R23-6-20230811","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/eurheartj\/ehq403","article-title":"Renal function and mortality following cardiac resynchronization therapy.","volume":"32","author":"Lin","year":"2011","journal-title":"Eur Heart J"},{"key":"R24-6-20230811","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1540-8159.2010.02705.x","article-title":"Response to cardiac resynchronization therapy in patients with heart failure and renal insufficiency.","volume":"33","author":"Adelstein","year":"2010","journal-title":"Pacing Clin Electrophysiol"},{"key":"R25-6-20230811","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1540-8159.2008.01043.x","article-title":"Elevated serum creatinine at baseline predicts poor outcome in patients receiving cardiac resynchronization therapy.","volume":"31","author":"Shalaby","year":"2008","journal-title":"Pacing Clin Electrophysiol"},{"key":"R26-6-20230811","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijcard.2006.11.015","article-title":"Prognostic value of renal function in patients with cardiac resynchronization therapy.","volume":"122","author":"Fung","year":"2007","journal-title":"Int J Cardiol"},{"key":"R27-6-20230811","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jacc.2010.06.060","article-title":"Impaired renal function is associated with echocardiographic nonresponse and poor prognosis after cardiac resynchronization therapy.","volume":"57","author":"Van Bommel","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R31-6-20230811","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure.","volume":"352","author":"Cleland","year":"2005","journal-title":"N Engl J Med"},{"key":"R32-6-20230811","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.cardfail.2008.03.009","article-title":"Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate.","volume":"14","author":"Boerrigter","year":"2008","journal-title":"J Card Fail"},{"key":"R33-6-20230811","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","article-title":"Cardiac-resynchronization therapy for mild-to-moderate heart failure.","volume":"363","author":"Tang","year":"2010","journal-title":"N Engl J Med"},{"key":"R34-6-20230811","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/europace\/eus152","article-title":"Independent predictors of mortality in patients with advanced heart failure treated by cardiac resynchronization therapy.","volume":"14","author":"Kreuz","year":"2012","journal-title":"Europace"},{"key":"R35-6-20230811","first-page":"A13947","article-title":"Cardiac resynchronization therapy prevents progression of renal failure in heart failure patients [Abstract].","volume":"124","author":"Jeevanantham","year":"2011","journal-title":"Circulation"},{"key":"R36-6-20230811","first-page":"A17791","article-title":"Renal response in patients with chronic kidney disease (CKD) predicts outcome following cardiac resynchronization therapy (CRT) [Abstract].","volume":"126","author":"Singal","year":"2012","journal-title":"Circulation"},{"key":"R37-6-20230811","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1540-8167.2008.01234.x","article-title":"Mortality of heart failure patients after cardiac resynchronization therapy: Identification of predictors.","volume":"19","author":"Bai","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R38-6-20230811","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jjcc.2012.06.001","article-title":"Impact of renal insufficiency on long-term clinical outcome in patients with heart failure treated by cardiac resynchronization therapy.","volume":"60","author":"Hosoda","year":"2012","journal-title":"J Cardiol"},{"key":"R39-6-20230811","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.cardfail.2012.09.003","article-title":"Comorbidity significantly affects clinical outcome after cardiac resynchronization therapy regardless of ventricular remodeling.","volume":"18","author":"Verbrugge","year":"2012","journal-title":"J Card Fail"},{"key":"R40-6-20230811","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11906-010-0142-2","article-title":"Does blockade of the renin-angiotensin-aldosterone system slow progression of all forms of kidney disease?","volume":"12","author":"Lattanzio","year":"2010","journal-title":"Curr Hypertens Rep"},{"key":"R41-6-20230811","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1046\/j.1523-1755.2003.00864.x","article-title":"Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia.","volume":"63","author":"Amann","year":"2003","journal-title":"Kidney Int"},{"key":"R42-6-20230811","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1681\/ASN.2006030204","article-title":"Cross-talk between the kidney and the cardiovascular system.","volume":"17","author":"Amann","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R43-6-20230811","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00428-003-0775-5","article-title":"Myocyte loss in early left ventricular hypertrophy of experimental renovascular hypertension.","volume":"442","author":"Buzello","year":"2003","journal-title":"Virchows Arch"},{"key":"R44-6-20230811","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jacc.2012.01.077","article-title":"Cardiorenal syndrome type 1: Pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure.","volume":"60","author":"Ronco","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R45-6-20230811","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2215\/CJN.03150509","article-title":"Cardiorenal syndrome in acute decompensated heart failure.","volume":"4","author":"Sarraf","year":"2009","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201308000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:43:20Z","timestamp":1786369400000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201308000-00006"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.00750113","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718016071.793478381","asserted-by":"object"}]},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}